Clovis Oncology is advancing the fight against cancer.
Founded in 2009, Clovis Oncology is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our pursuit is to improve the lives of people living with cancer. We believe our approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy.
Our product development programs generally target specific subsets of cancer, and we seek to simultaneously develop, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, we have the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths.
Clovis Oncology’s management team has extensive experience in the development of novel cancer therapies and a shared commitment to the company’s vision for meaningful improvements in the lives of patients with cancer.
Clovis Oncology (NASDAQ: CLVS) is headquartered in Boulder, Colorado.
Please visit our website for more information, including additional office locations in the U.S. and Europe.
Company Details
- Employees
- 65
- Founded
- -
- Address
- 5500 Flatiron Parkway, Boulder,co 80301,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- clovisoncology.com
- HQ
- Boulder, CO
Clovis Oncology Questions
Clovis Oncology's website is clovisoncology.com
Clovis Oncology's LinkedIn profile is https://www.linkedin.com/company/clovis-oncology
Clovis Oncology has
65 employees.
View email and phone details for 65
employees at Clovis Oncology.
Clovis Oncology's industry is
Biotechnology Research
Clovis Oncology's top competitors are
Kura Oncology, Inc.,
Elevation Oncology,
Dava Oncology,
Karyopharm Therapeutics Inc.,
Vertex Pharmaceuticals,
Aveo Oncology,
Verastem Oncology,
Strata Oncology,
Precision Oncology .,
Pharma&.
Clovis Oncology's categories are Biotechnology Research
Clovis Oncology's founding year is 2009
